Abivax SA Sponsored ADR
(NASDAQ: ABVX)

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

109.965

-0.675 (-0.61%)
Range 109.080 - 112.500   (3.14%)
Open 112.500
Previous Close 110.640
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 97,026
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis